237 results on '"Strathmann, Frederick G."'
Search Results
2. Retraction notice to “Distributions of alcohol use biomarkers including ethanol, phosphatidylethanol, ethyl glucuronide and ethyl sulfate in clinical and forensic testing” [Clin. Biochem. 82 (2020) 85–89]
3. Association of PTHrP levels in CSF with Alzheimer’s disease biomarkers
4. Inductively coupled plasma mass spectrometry assay for quantification of free infliximab in serum
5. List of contributors
6. Toxic metals
7. Toxicity of heavy metals—case study
8. Parathyroid hormone related protein concentration in human serum and CSF correlates with age
9. Establishment and verification of chromium and cobalt concentrations in joint fluids from a reference population
10. Simple dilute-and-shoot method for urinary vanillylmandelic acid and homovanillic acid by liquid chromatography tandem mass spectrometry
11. The significance of reporting to the thousandths place: Figuring out the laboratory limitations
12. Development of a liquid chromatography–tandem mass spectrometry method to address the increased utilization of umbilical cord in the assessment of in utero drug exposure
13. Analysis of umbilical cord tissue as an indicator of in utero exposure to toxic adulterating substances
14. Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?
15. Ordering of the Serum Angiotensin-Converting Enzyme Test in Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy: An Avoidable but Common Error
16. Simplified sample preparation in the simultaneous measurement of whole blood antimony, bismuth, manganese, and zinc by inductively coupled plasma mass spectrometry
17. Blood-based biomarkers for traumatic brain injury: Evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives
18. Primary Prevention of Pediatric Lead Exposure Requires New Approaches to Transfusion Screening
19. Patient Data Algorithms
20. Thyroglobulin Antibody Screen Prior to Mass Spectrometry Provides Measurable Cost Savings and Optimal Laboratory Utilization
21. Cost and Efficacy Assessment of an Alternative Medication Compliance Urine Drug Testing Strategy
22. Utilization of the clinical laboratory for the implementation of concussion biomarkers in collegiate football and the necessity of personalized and predictive athlete specific reference intervals
23. 3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adults
24. Simulations of delta check rule performance to detect specimen mislabeling using historical laboratory data
25. A Hybrid Approach to Urine Drug Testing Using High-Resolution Mass Spectrometry and Select Immunoassays
26. Qualitative LC/Q-TOF Analysis of Umbilical Cord Tissue via Data-Dependent Acquisition as an Indicator of In Utero Exposure to Toxic Adulterating Substances
27. RETRACTED: Distributions of alcohol use biomarkers including ethanol, phosphatidylethanol, ethyl glucuronide and ethyl sulfate in clinical and forensic testing
28. Pathology Consultation on Urine Compliance Testing and Drug Abuse Screening
29. Total Arsenic Screening Prior to Fractionation Enhances Clinical Utility and Test Utilization in the Assessment of Arsenic Toxicity
30. Chapter 21.1 - Toxicity of heavy metals—case study
31. Chapter 21 - Toxic metals
32. Qualitative LC–Q-TOF Analysis of Umbilical Cord Tissue via Data-Dependent Acquisition as an Indicator of In Utero Exposure to Toxic Adulterating Substances.
33. 44 - Toxic elements
34. Textbook Contributors
35. Use of the BD Vacutainer Rapid Serum Tube Reduces False-Positive Results for Selected Beckman Coulter Unicel DxI Immunoassays
36. The Utility of Spot vs 24-Hour Urine Samples for Metal Determination in Veterans With Retained Fragments
37. Distributions of alcohol use biomarkers including ethanol, phosphatidylethanol, ethyl glucuronide and ethyl sulfate in clinical and forensic testing
38. Challenges of High-Resolution Mass Spectrometry For Detecting Designer Drugs
39. 42 - Toxic Elements
40. The Utility of Spot vs 24-Hour Urine Samples for Metal Determination in Veterans With Retained Fragments.
41. Unrecognized Elevations of Toxic Elements in Urine and Blood Highlight the Potential Need for a Broader Approach to Exposure Assessment
42. Simultaneous Determination of Uranium and Depleted Uranium Isotopic Ratio Using Inductively Coupled Mass Spectrometry
43. Determination of Thirteen Trace and Toxic Elements in Urine Using Inductively Coupled Mass Spectrometry
44. Lowering the Bar for Mass Spectrometry: A Comparison between Immunoassay and Rapid Time-of-Flight for Presumptive Screening of Drugs in Urine
45. 58 Was That the Right Decision? A Post-Mortem Analysis of a Multi-Year Quality Improvement Process
46. 50 Retrospective Analysis of Blood Lead Levels in US Population: Assessing the Role of a National Reference Laboratory in Monitoring and Predicting Lead Contamination Events
47. Body fluid matrix evaluation on a Roche cobas 8000 system
48. Up in Smoke: Uncovering a Lack of Evidence for Proton Pump Inhibitors as a Source of Tetrahydrocannabinol Immunoassay False Positives
49. An exploratory study Evaluating the impact of opioid and non-opioid pain medications on serum/plasma free testosterone and free estradiol concentrations
50. Internal Hydrolysis Indicator for Sample Specific Monitoring of β-Glucuronidase Activity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.